呼吸器疾患における吸入器のスキームスイッチを導入するための重要な要因:改変名義グループ技術 (NGT) を使用して生成された国際的な専門家コンセンサス
Omar S Usmani1, Nicolas Roche2, Job F M van Boven3
1National Heart and Lung Institute, Imperial College London, London, UK.
NPJ primary care respiratory medicine
|February 23, 2026
まとめ
専門家のコンセンサスは,喘息とCOPDにおける吸入器スイッチの臨床的ニーズと患者の関与を優先することを強調しています. 安全なスイッチングには,費用や環境要因ではなく,協議,同意,教育が必要です.
科学分野:
- 呼吸器医学とは
- 保健政策 保健政策 保健政策
- 患者の安全性についてです.
背景:
- 吸入器の切り替えは,喘息とCOPDの管理において一般的です.
- 現在のガイドラインには,安全で効果的な吸入器の移行のための包括的な戦略がない.
- インハラースイッチプロトコルの標準化には,専門家によるコンセンサスが必要である.
研究 の 目的:
- 最適な吸入器のスイッチング慣行に関する国際的な専門家のコンセンサスを確立する.
- 適切な状況,利害関係者の役割,および吸入器のスイッチのための重要なステップを定義する.
- 臨床医や意思決定者に,安全で効果的な吸入器への移行について情報を提供するためです.
主な方法:
- 国際名義グループテクニックは,臨床,支払者,患者に関する専門家8名で構成されています.
- インハレーター交換のドライバーと状況に関するアイデアの生成と評価.
- ステークホルダーマッピングのための意思決定部門の枠組みの適用.
主要な成果:
- 臨床的および患者中心のドライバー (例えば,疾病管理,技術) は,吸入器のスイッチにとって最重要です.
- 患者の安全が第一の関心事であり,相談,同意,教育,およびフォローアップを必要とします.
- 費用と環境要因は,吸入器の切り替えの最も重要でない要因と考えられた.
結論:
- 吸入器のスイッチは,コストや持続可能性よりも臨床的ニーズと患者の関与を優先すべきである.
- 政策立案者は,大規模な吸入器スイッチの導入に伴う時間と複雑さを考慮する必要があります.
- 標準化されたプロトコルの開発は,呼吸器患者のための安全で効果的な吸入器移行を保証します.
関連する概念動画
Inhaled Medications
889
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
889
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
COPD: Management Using Bronchodilators and Corticosteroids
907
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
907
Asthma-IV: Nursing Management
3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.9K
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K


